New scientific review analyzes the connection between immunity and post-COVID cognitive alterations
This publication comprehensively analyzes how SARS-CoV-2 infection can affect cognitive function through immunological mechanisms and alterations of the blood-brain barrier.
-
Sant Joan de Déu coordinates the European project AriChall to promote a new clinical trial in pediatric leukemia
Sant Joan de Déu coordinates the European project AriChall, an international initiative that promotes a new clinical trial with the aim of identifying a treatment for children with acute lymphoblastic leukemia (ALL) in first relapse through the CAR-T ARI-0001 therapy.
-
New study reveals that one in four patients who start treatment with benzodiazepines uses them for a long time
According to the data analyzed, 27.1% of patients who receive a new prescription for this type of drug end up becoming long-term users after three months, and 14.5% are still so after six months.
-
Sant Joan de Déu launches a new interactive games space to bring research closer to patients and families
-
An intervention based on the Mediterranean diet during pregnancy positively modifies the mother’s gut microbiota
The IMPACT BCN study analyses how the Mediterranean diet and stress reduction during pregnancy influence the maternal gut microbiota.
-
Sant Joan de Déu launches a new interactive games space to bring research closer to patients and families
The initiative, called "Play and learn about research", is located in the main lobby of the Hospital and combines puzzles, educational videos and scientific discoveries.
-
Efficacy of a drug demonstrated in preclinical models to halt rhabdomyosarcoma growth
The research team led by the Institut de Recerca Joan de Déu (IRSJD) and the Hospital del Mar Research Institute has, for the first time, demonstrated the efficacy of a drug in animal models developed from samples of patients from the Sant Joan de Déu Hospital.
-
An innovative treatment driven by Sant Joan de Déu improves neurodevelopment in two children with Menkes disease
A study led by the Institut de Recerca Sant Joan de Déu (IRSJD) and the Hospital Sant Joan de Déu (HSJD) publishes the first positive clinical results with elesclomol-copper in infants affected by Menkes disease.
-
Genetic events that could trigger leukemia in patients with a rare genetic disorder are deciphered
The study has been carried out thanks to advanced models of this genetic disorder generated by the researchers, which are presented as a key tool in its investigation.
